| Tretinoin | Approved Investigational Nutraceutical | NPC2 | 10577 |
upregulated | Tretinoin results in increased expression of NPC2 mRNA | 14q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NPEPPS | 9520 |
upregulated | Tretinoin results in increased expression of NPEPPS mRNA | 17q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | NPFFR2 | 10886 |
upregulated | Tretinoin results in increased expression of NPFFR2 mRNA | 4q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NPIPA1 | 9284 |
downregulated | Tretinoin results in decreased expression of NPIPA1 mRNA | 16p13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | NPM1 | 4869 |
downregulated | Tretinoin results in decreased expression of NPM1 mRNA | 5q35.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NPNT | 255743 |
upregulated | Tretinoin results in increased expression of NPNT mRNA | 4q24 | |
| Tretinoin | Approved Investigational Nutraceutical | NPPB | 4879 |
upregulated | Tretinoin results in increased expression of NPPB mRNA | 1p36.22 | |
| Tretinoin | Approved Investigational Nutraceutical | NPR1 | 4881 |
downregulated | Tretinoin results in decreased expression of NPR1 mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NPR3 | 4883 |
downregulated | Tretinoin results in decreased expression of NPR3 mRNA | 5p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NPTX1 | 4884 |
upregulated | Tretinoin results in increased expression of NPTX1 mRNA | 17q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NPTX2 | 4885 |
downregulated | Tretinoin results in decreased expression of NPTX2 mRNA | 7q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NPY | 4852 |
downregulated | Tretinoin results in decreased expression of NPY mRNA | 7p15.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NPY1R | 4886 |
upregulated | Tretinoin results in increased expression of NPY1R mRNA | 4q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NPY2R | 4887 |
downregulated | Tretinoin results in decreased expression of NPY2R mRNA | 4q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NPY5R | 4889 |
upregulated | Tretinoin results in increased expression of NPY5R mRNA | 4q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NQO1 | 1728 |
upregulated | Tretinoin results in increased expression of NQO1 mRNA | 16q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NR0B1 | 190 |
upregulated | Tretinoin results in increased expression of NR0B1 mRNA | Xp21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NR0B2 | 8431 |
upregulated | Tretinoin results in increased expression of NR0B2 mRNA | 1p36.11 | |
| Tretinoin | Approved Investigational Nutraceutical | NR1H3 | 10062 |
upregulated | Tretinoin results in increased expression of NR1H3 mRNA | 11p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NR1I3 | 9970 |
upregulated | Tretinoin results in increased expression of NR1I3 mRNA | 1q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NR2C2AP | 126382 |
downregulated | Tretinoin results in decreased expression of NR2C2AP mRNA | 19p13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | NR2F1 | 7025 |
upregulated | Tretinoin results in increased expression of NR2F1 mRNA | 5q15 | |
| Tretinoin | Approved Investigational Nutraceutical | NR2F2 | 7026 |
downregulated | Tretinoin results in decreased expression of NR2F2 mRNA | 15q26.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NR2F2 | 7026 |
upregulated | Tretinoin results in increased expression of NR2F2 mRNA | 15q26.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NR3C1 | 2908 |
upregulated | Tretinoin results in increased expression of NR3C1 mRNA | 5q31.3 | |